INS and metabolic syndrome: Enhanced expression of PPARγ likely drives improved adipocyte differentiation, fatty acid oxidation, and insulin signaling in adipose and liver tissues, thereby attenuating dyslipidemia and hyperglycemia; these effects are amplified in the combined group.